Denise Plunkett and Nicholas Gaglio Named to Crain’s New York Business Notable Litigators & Trial Attorneys
March 25, 2025
Axinn litigation practice chair Denise Plunkett and partner Nicholas Gaglio have been named “Notable Litigators & Trial Attorneys” by Crain’s New York Business. Chosen through nominations from peers and clients, the honorees are recognized for their outstanding achievements, professional excellence, and significant contributions to their industries.
Denise Plunkett is a trial lawyer with more than 25 years of experience handling an impressive array of high-stakes commercial disputes and high-profile antitrust cases. She has served as lead trial counsel in well over a dozen jury trials of varying types.
Drawing on more than twenty years of experience, Nick Gaglio counsels clients on a full range of antitrust issues, including litigation, mergers, civil non-merger and criminal cartel investigations, internal investigations, and counseling.
About Axinn
Incisive. Inclusive. Invested. Inquisitive. We’re Axinn. Focusing on antitrust, intellectual property, and litigation, we make it our mission to understand your business, so we can anticipate every move. Acting with precision and conviction, we protect and accelerate your business growth, always thinking ahead.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
NJSBA Annual Meeting and Convention 2025
Speaking Engagement
Intellectual Property
CompLaw Antitrust West Coast Conference 2025
Speaking Engagement
Antitrust
AHLA Health Care Transactions Program 2025
Sponsorship
Antitrust
ACI 21st Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
ABA 73rd Annual Section of Antitrust Law Spring Meeting
Speaking Engagement
Antitrust
AIPLA CLE Web Series: Hot Topics in Chemical & Biotech Patent Practice
Speaking Engagement
17th Annual Practitioners’ Think Tank on ITC Litigation & Enforcement
Speaking Engagement
Intellectual Property
Antitrust Enforcement Trends and Policies in 2025: Unfair Competition, Merger Policies, Premerger Procedures
Webinar
Antitrust
CompLaw Nordic 2025
Speaking Engagement
Antitrust
Compounding Problems: Recent Decisions on Tirzepatide Highlight Interplay Between FDA Anti-Compounding Enforcement and Private Intellectual Property Rights
Axinn Viewpoints
Intellectual Property